ScholarIQanswers from OpenAlex

Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs

PaperCitations, authors & open-access status

Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs have?

ScholarIQcitation count

Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs has 135 citations in the OpenAlex counts ScholarIQ stores.

When was Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs published?

ScholarIQyear

Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs has 2020 year in the ScholarIQ index.

What is the open-access status of Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs?

ScholarIQoa status

Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs has green oa status in the ScholarIQ index.

What is the DOI of Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs?

ScholarIQdoi

The DOI for Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs is on the source record.

What is the OpenAlex record for Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs?

ScholarIQopenalex

The OpenAlex for Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial